ColoHealth
Blood-based methylated SEPT9 colorectal cancer testing family; current ColoHealth Direct LDT and historical FDA device lineage are modeled separately.
- Developer
- New Day Diagnostics
- Intended use
- Screening
- Cancer scope
- Colorectal cancer
- Specimen
- Peripheral whole blood
- Molecular modality
- DNA methylation
- Current version
- ColoHealth Direct current LDT (2026)
- Evidence context
- 2 structured studies · 4 indexed performance results · 4 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.